Cardiovascular Evaluation Before Renal Transplantation

NCT ID: NCT01064674

Last Updated: 2010-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-12-31

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Due to rising importance of cardiovascular disease before and after renal transplantation we have changed our standard diagnostic procedure and perform stress echocardiography and myocardial scintigraphy. We would like to monitor these results and the outcome of our patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic kidney disease is a well-known risk factor for cardiovascular disease. Patients waiting for a renal transplantation usually undergo an extensive diagnostic procedure to avoid complications after transplantation such as neoplasia or inflammation. In the past years, cardiovascular complications before and after renal transplantation have gained more attention. We therefore have changed our standard diagnostic procedure before renal transplantation and perform stress echocardiography and myocardial scintigraphy. Thus we would like to evaluate our new standard diagnostic procedure and observe the results of these diagnostic procedures as well as their impact on clinical outcome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

before renal transplantation

Patients with CKD IV° to V° who are actually registering for a renal transplantation in our department.

diagnostic procedure

Intervention Type OTHER

Cardiovascular diagnostic standard procedure before renal transplantation using stress echocardiography and stress myocardial scintigraphy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diagnostic procedure

Cardiovascular diagnostic standard procedure before renal transplantation using stress echocardiography and stress myocardial scintigraphy.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

diagnostic standard procedure

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* endstage renal disease
* preparing for renal transplantation

Exclusion Criteria

* children (\< 18 years)
* women who are pregnant or nursing
* patients who are also awaiting heart transplantation or have already a heart transplant
* severe mental illness
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Muenster

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Internal Medicine D, University Hospital of Muenster

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Barbara Suwelack, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Muenster

Hermann Pavenstädt, MD

Role: STUDY_CHAIR

University Hospital Muenster

Holger Reinecke, MD

Role: STUDY_CHAIR

University Hospital Muenster

Otmar Schober, MD, PhD

Role: STUDY_CHAIR

University Hospital Muenster

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Internal Medicine D, University Hospital Muenster

Münster, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Barbara Suwelack, MD

Role: CONTACT

00492518347540

Viola Malyar, MD

Role: CONTACT

00492518347540

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Barbara Suwelack, MD

Role: primary

00492518347540

Viola Malyar, MD

Role: backup

00492518347540

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HerzundNierenMünster

Identifier Type: REGISTRY

Identifier Source: secondary_id

KVDiagnostikpratransplantation

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Genomics in Heart Transplants
NCT06012162 NOT_YET_RECRUITING